A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.
This study has been terminated.
(This study was stopped 20 May 2010 due to strategic considerations)
First Posted: August 14, 2008
Last Update Posted: September 21, 2011
Information provided by (Responsible Party):
Abbott ( Abbott Products )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||August 2010|
|Primary Completion Date:||August 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||September 9, 2011|